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 Abstract—The most widely used method to assess motor 
functioning in Parkinson’s Disease (PD) patients is the Unified 
Parkinson’s Disease Rating Scale-III (UPDRS-III). The UPDRS-
III has limited ability to detect subtle changes in motor symptoms. 
Alternatively, graphical tasks can be used to provide objective 
measures of upper limb motor dysfunction. The present study 
investigated the validity of such graphical tasks to assess upper 
limb function in PD patients and their ability to detect subtle 
changes in performance. Fourteen PD patients performed 
graphical tasks before and after taking dopaminergic medication. 
Graphical tasks included figure tracing, writing and a modified 
Fitts’ task. The Purdue pegboard test was performed to validate 
these graphical tasks. Movement time (MT), writing size and the 
presence of tremor were assessed. Movement time (MT) on the 
graphical tasks correlated significantly with performance on the 
Purdue pegboard test (Spearman’s rho > 0.65; p < 0.05). MT 
decreased significantly after the intake of dopaminergic 
medication. Tremor power decreased after taking dopaminergic 
medication in most PD patients who suffered from tremor. 
Writing size did not correlate with performance on the Purdue 
pegboard test, nor did it change after taking medication. Our set 
of graphical tasks is valid to assess upper limb function in PD 
patients. MT proved to be the most useful measure for this 
purpose. The response on dopaminergic medication was optimally 
reflected by an improved MT on the graphical tasks in 
combination with a decreased tremor power, whereas writing size 
did not respond to dopaminergic treatment. 
  
Index Terms—Parkinson’s disease, graphical tasks, 
handwriting, drawing, upper limb function, validity, 
bradykinesia, tremor, micrographia.  
I. INTRODUCTION 
ORRECT diagnosis of Parkinson’s disease (PD), a 
neurodegenerative movement disorder, is essential for 
optimal treatment and prognosis. Diagnosis is based upon the 
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cardinal motor symptoms of PD: bradykinesia (slow 
movement), rigidity (muscle stiffness), resting tremor 
(trembling of a body part in rest) and postural and gait 
impairment [1]. The motor part (part III) of the most recent 
revision of the Unified Parkinson’s Disease Rating Scale by the 
Movement Disorder Society (MDS-UPDRS-III) is the most 
widely used scale in clinical practice to assess parkinsonian 
symptoms [1], [2]. However, the MDS-UPDRS-III has several 
limitations. Firstly, the MDS-UPDRS-III needs to be evaluated 
by a trained assessor, which makes it less suitable for home-
based monitoring. Secondly, the inter-rater reliability is high for 
movement disorders specialists, but unfortunately not all 
patients have access to specialized movement disorder centers, 
which negatively influences the accuracy and reliability of the 
MDS-UPDRS-III. Thirdly, the MDS-UPDRS-III has limited 
ability to detect subtle changes in motor function, which are 
common in early PD. Therefore, an objective, sensitive, reliable 
and accurate assessment system could potentially overcome 
these limitations of the existing MDS-UPDRS-III scale. 
Objective motor assessment systems have been developed 
previously, such as Kinesia (Great Lakes NeuroTechnologies, 
USA) [3], [4] and Parkinson’s KinetiGraph (PKG, Global 
Kinetics Corporation, Australia). These systems involve 
movement sensors that need to be worn on the index finger 
(Kinesia) or wrist (PKG) and are used to assess and monitor 
movement of the upper limb. Another tool which might be 
useful for monitoring employs a digital tablet and pen and can 
be used to perform and record graphical tasks, i.e. handwriting 
and drawing [5]. Similar to the Kinesia and PKG systems, the 
pen and tablet tool is non-invasive, portable, and can be used 
easily at home without an examiner. An advantage of Kinesia 
and a digital tablet compared to PKG is that specific short-term 
tasks can be performed several times a day and that patients 
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don’t have to wear a sensor for multiple days. An advantage of 
a digital tablet when compared to Kinesia is that a clinician can 
obtain feedback on how tasks were performed, because pen-tip 
movements are recorded. On the contrary, if a patient performs 
a task while wearing the Kinesia-sensor, like holding the arms 
in a specific posture, there is no way to verify whether the task 
was performed correctly. 
Graphical tasks employing a digital tablet provide objective 
measures of important motor symptoms of PD and were used 
previously to show differences between PD patients and healthy 
control (HC) participants [6]–[10]. Medication effects have also 
been investigated in PD patients using such a set-up [11]–[15]. 
In general, these studies investigated one graphical task. 
However, to assess and monitor PD, it is important to measure 
several aspects of motor behavior, because PD patients do not 
always suffer from the same combination of symptoms, and 
treatment could have variable effects on different aspects of 
motor functioning of PD patients. Therefore, the assessment 
battery of the current study consists of several graphical tasks, 
providing useful measures for bradykinesia, tremor and 
micrographia [6].  A newly developed system consisting of a 
pen and tablet and custom software, based on a concept by 
Manus Neurodynamica Ltd, was used. The advantage of this 
system is that it includes an integrated comprehensive sensor 
and data acquisition system for highly accurate recordings and 
analysis. The aim of the current study was to investigate the 
validity of these graphical tasks to assess upper limb function 
in PD patients. Validity of comparable methods in the literature 
is mostly determined by their correlation with the total UPDRS-
III [11], [16]–[19]. However, our graphical tasks only involve 
movements of the upper limb, and since the MDS-UPDRS-III 
score involves more than just upper limb functioning, it is less 
suitable for validation. Therefore, a validated test for upper limb 
functioning [17], [20], [21], the Purdue pegboard test (PPT), 
was used as reference, in addition to MDS-UPDRS-III scores, 
involving hand items only.   
Graphical tasks in this study include simple tracing and 
writing tasks and a modified Fitts’ task, which are easy to 
perform and cover a large range of upper limb functions. A 
resting task was included to measure resting tremor, because 
PD tremor is typically a resting tremor [22]. Furthermore the 
modified Fitts’ task was used to assess the speed-accuracy trade 
off, which may be impaired in PD patients [23]. This 
exploratory study investigated which of the tasks could be used 
most optimally to assess upper limb motor functioning and to 
detect changes in motor performance after use of dopaminergic 
medication in PD patients. 
II. METHODS 
A. Participants 
Fourteen PD patients performed the tasks with their right 
hand. PD patients were diagnosed by a movement disorders 
specialist (according to the UK Parkinson’s Disease Society 
Brain Bank criteria [24]) and were treated at the movement 
disorders clinic of the University Medical Center Groningen 
(UMCG). Since the patients had to be able to hold a pen for at 
least 30 minutes and perform tracing and writing tasks, PD 
patients in relatively early stages of the disease (Hoehn and 
Yahr stages 1-2 [25] were selected. Table 1 provides a summary 
of the PD patient characteristics. Patients agreed with overnight 
withdrawal of their usual dose of dopaminergic medication. 
Exclusion criteria were a neurological or motor disorder other 
than PD and a low score (< 26) on the Mini Mental State 
Examination (MMSE) to ensure understanding of task 
instructions. All patients signed informed consent and the 
protocol was approved by the Medical Ethical Committee of the 
UMCG.  
B. Experimental design 
Patients were seated in front of a table in a comfortable 
position to write. A tablet computer (ASUS Eee Slate EP121) 
and a newly developed digital pen with custom software were 
used. Position of the pen-tip on the tablet and gyroscope signals 
in three directions (pitch, yaw and roll) was recorded. All 
recordings had a sampling frequency of 200 Hz. The pen had a 
wireless connection to the tablet. Patients performed seven 
tasks (see below). The examiner was seated behind an operator 
computer to start and stop recordings and determined whether 
patients executed the tasks correctly. If a task was executed 
incorrectly, the recording was stopped and restarted after re-
instruction. The OFF measurement was performed in the 
morning, after overnight withdrawal of medication. Thereafter, 
patients took their medication and had a one-hour break, to 
allow for an optimal medication effect. After one hour the ON 
measurement was performed. The hand items of the MDS-
UPDRS-III were assessed and videotaped and scored by a 
clinician from the UMCG (RWKB), who was blinded to the 
medication status of the patients. 
C. Tasks 
Patients were instructed to start each task after a signal of the 
examiner. Firstly, a recording at rest (30 seconds) was 
performed. Patients were seated with the right elbow resting on 
the table, the hand resting on the tablet and the pen-tip touching 
a target (filled circle, 0.7 cm in diameter) in the center of the 
tablet. Next, the patients subsequently traced circle, spiral and 
zigzag figures which were displayed on the tablet (see Figure 
1). The circle and spiral were traced ten times in a clockwise 
direction, starting from the 12 o’clock position (circle) or from 
inside to outside (spiral). The zigzag was traced five times, from 
left to right and back. The next task consisted of writing 
‘elelelel’ five times with each phrase starting at the left side of 
the tablet with visual feedback on the screen. An example was 
provided on paper on the table above the tablet. Thereafter, a 
modified Fitts’ task was performed, which was similar to Fitts’ 
original task [26] but adapted to the dimensions of our system. 
Patients touched two targets (filled circles, placed on an 
imaginary horizontal line in the middle of the tablet) alternately 
with the pen-tip as fast and as accurately as possible (20 
seconds). The distance between the targets was 7 cm for 
subtasks 1 to 4 and 20 cm for subtasks 5 to 8, while the diameter 
of the targets increased (0.7, 1.3, 1.9, 2.5 cm). Finally, the PPT 
was performed, which employed a board with a vertically 
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oriented row with 25 holes and metal pins located in a reservoir 
at the top. We limited the PPT to the right hand task, similar to 
the other graphical tasks. Patients were instructed to place as 
many pins as possible in the holes within 30 seconds. 
Participants were allowed to practice before the test [27].  
 
 
Figure.1. Templates and their dimensions for the tracing tasks: a circle, spiral 
and zigzag figure. 
 
D. Data analysis 
Graphical tasks were analyzed using Matlab (R2014A). 
Mean movement time (MT) per trial was calculated for the 
tracing tasks (CircleMT; SpiralMT and ZigzagMT), using the x 
and y coordinates of the pen-tip. 
 
1) Elelelel writing task 
The pen-tip position data (x and y coordinates) were 
preprocessed. First, the data were split into separate segments, 
where each segment represented one line of text. This was done 
using an ‘in range’ signal, which indicates whether or not the 
pen is in detection range of the tablet employing that, after 
writing one line of text, the patient lifts the pen so that it is 
outside the detection range of the tablet. Subsequently, the 
segments corresponding to an ‘e’ or an ‘l’ were identified. The 
shapes in each line were recognized by using a state machine 
that employs the direction of change of the pen-tip position as 
input (similar to the method used in [6], see Supplementary 
Methods 1). For each detected letter ‘e’ and ‘l’, movement time 
(MT) was calculated by counting the samples and dividing it by 
200 (since the sample frequency was 200 Hz). MT was 
averaged over all detected ‘e’s’ and ‘l’s’, resulting in the 
features E_MT and L_MT. The mean width and height of the 
letters was also calculated, using the x and y coordinates of the 
pen-tip (E_Width; E_Height; L_Width; L_Height). 
 
2) Modified Fitts task analysis 
The modified Fitts’ task was analyzed according to Fitts’ law 
[26]. The tradeoff between speed and accuracy was modeled by 
Fitts [26] in the time required for movement (T): 
 
𝑇𝑇 = 𝑎𝑎 + 𝑏𝑏 �log 2𝐴𝐴
𝐷𝐷
� 
Here, A is the distance between targets and D the target 
diameter. The part log(2A/D) is known as the index of difficulty 
(ID). When multiple IDs are available, a and b can be estimated 
by linear regression. In our modified Fitts’ task eight IDs could 
be determined, since the task consists of eight subtasks, with 
varying difficulty. For each patient the mean T for each ID 
(each subtask) was calculated as the average time needed to 
move the pen from one target to the other, to allow 
determination of the relationship between movement time and 
ID. A linear curve was then fitted to the data points and a least 
squares calculation was used to determine the goodness of fit 
(FittsR2). FittsR2 refers to the degree of compliance with Fitts’ 
law and was determined for each patient. The slope of the fitted 
curve (FittsSlope) describes the extent to which the 
performance becomes slower with an increase in ID and was 
calculated for each patient, as well.  
 
3) Tremor analysis 
For the resting, circle, and spiral tasks the gyroscope signals 
were analyzed to assess tremor. In detail, the procedure to 
extract tremor features consists of the following steps: 
1. The gyroscope signals were filtered with a 5 samples 
long running median filter to remove artefactual peaks. 
2. To dampen the lowest frequencies (< 3 Hz) to remove 
the frequency components not related to tremor, the 
gyroscope signals were filtered by removing the output 
of a second order Savitzky-Golay filter. The frame size 
of the filter is 0.33 times the sample rate of the signal for 
the circle and spiral tasks and 0.5 times the sample rate 
for the rest task. This filtering process increases the 
signal to noise ratio for the determination of the 
dominant tremor frequency. 
3. A principal component analysis was performed on the 
three filtered gyroscope signals (pitch, yaw and roll) 
only for the periods in which the patient was performing 
the task. Then, the first principal component was 
selected. 
4. Next, the power spectral density (PSD) of the first 
principal component was estimated using Welch’s 
method (3 s segments with 2 s overlap, Fourier 
transform length of 2048 samples) and the band power 
in a 1 Hz band around each frequency (overlapping bins) 
was computed. 
5. The PSD plots were inspected to determine whether PD 
patients showed tremor during the tasks. This was done 
by visually checking whether a clear peak between 4 and 
9 Hz (typical tremor band [27]) was present in the PSD 
plot. Only the PD patients who did show a clear peak 
were selected for further analysis. 
6. The frequency with the highest band power was selected 
as the tremor frequency for the PD patients who were 
selected in the previous step. The relative power band 
was calculated by dividing the power in the 1 Hz band 
around the peak frequency by the total power. 
  
JBHI Reference: JBHI-00373-2015                                 4 
 
E. Statistical analysis 
Statistical analyses were conducted using SPSS (IBM SPSS 
Statistics 22). Normality of measures was assessed by the 
Shapiro-Wilk test. Validity was estimated by analyzing the 
correlation between performance on the graphical tasks and on 
the PPT. The PPT yields scores of ordinal level and therefore 
the correlation between PPTright and the tracing, writing and 
modified Fitts’ task measures was analyzed by Spearman’s rank 
correlation. The correlation between performance on the 
graphical tasks and the MDS-UPDRS-III-bradykinesia 
subscore was also assessed. A Spearman’s rank correlation 
coefficient between 0.90 and 1.00 was regarded as a very high 
correlation, between 0.70 and 0.90 as a high correlation, 
between 0.50 and 0.70 as a moderate correlation, between 0.30 
and 0.50 as a low correlation and below 0.30 as a negligible 
correlation [28]. Response to dopaminergic medication was 
determined by a significant improvement on the movement 
time, writing size, FittsSlope and FittsR2 and tremor measures 
after taking dopaminergic medication, by a paired t-test for 
normally distributed measures or a related-samples Wilcoxon 
signed rank test, otherwise.  
III. RESULTS 
All PD patients (N=14, mean age 68 years, 10 male; see 
Table 1) completed the tasks OFF and ON medication. Some 
patients, who had missing data due to a technical problem, were 
excluded from statistical analysis (see Table 2). There was no 
significant difference between the MDS-UPDRS-III-
bradykinesia subscore OFF and ON medication.  
A. Validity  
MT on the circle, spiral and zigzag tasks correlated 
significantly with the PPTright score: CircleMT (ρ= -0.69, 
p<0.001), SpiralMT (ρ=-0.63, p<0.001) and ZigzagMT (ρ = -
0.66, p<0.001). The MT measures of the ‘elelelel’ writing task 
showed low correlations with the PPTright score (E_MT: ρ = -
0.33, p=0.08 and L_MT: ρ= -0.37, p=0.05). None of the writing 
size measures correlated with the PPTright score. FittsSlope 
correlated moderately with the PPTright score (ρ=0.64, 
p<0.001) while FittsR2 did not correlate with the PPTright 
score. Figure 2 shows two examples of the relationship between 
the PPTright score and graphical task measures. None of the 
graphical task measures correlated with the MDS-UPDRS-III-
bradykinesia subscore. 
B. Response to dopaminergic medication 
Table 2 provides the test statistics for the response to 
dopaminergic medication.  CircleMT, SpiralMT, E_MT, L_MT 
and FittsSlope were significantly lower at ON medication as 
compared to OFF medication (related-samples Wilcoxon 
signed rank test, p<0.05). The other measures did not respond 
to dopaminergic medication. 
C. Tremor assessment 
If patients did not suffer from tremor during the graphical 
tasks, the tremor (peak) frequency could not be determined. 
Further analysis was therefore only performed on patients 
exhibiting tremor during at least one of the tasks, indicated by 
the availability of tremor frequencies. This group was too small 
to perform statistical analysis, so we investigated each of the 
patients individually. Table 3 shows the results of the tremor 
analysis. Two patients exhibited tremor during the resting task 
at OFF medication, six patients during the circle task at OFF 
medication, and five patients during the spiral task at OFF 
medication. In general, relative power decreased after taking 
medication and for most of the patients no tremor frequency 
was seen during the ON medication phase. Patient PD008 
 
TABLE I 
SUMMARY OF PD PATIENT CHARACTERISTICS 
      
Years since 
diagnosis 
 MDS-UPDRS-III Purdue pegboard 
      Bradykinesia subscore Tremor subscore Right hand 
ID Gender Age MMSE D H&Y OFF ON OFF ON OFF ON 
PD001 M 73 26 PD 3 2 1a 0b 0c 0c 9 9 
PD002 M 78 29 PD 4 1 0a 0 0c 0 11 11 
PD003 M 60 28 PD 2 2 6 0 0c 0 7 8 
PD004 M 81 29 PD 0 2 0 1 0 0 8 8 
PD005 F 70 29 PD 3 2 1 0 0d 0 12 13 
PD006 M 69 28 PD 10 2 1 1 0 0 8 4 
PD007 F 76 30 PD 1 2 0 0 0 0 8 9 
PD008 F 68 26 PD 1 2 3 ** 0 ** 7 7 
PD009 M 69 30 PD 10 2 2 0 0 0 7 8 
PD010 M 67 29 PD 6 1 0 0 0 0 11 11 
PD011 F 50 28 PD 8 2 0 0 2 0 12 13 
PD012 M 66 30 tdPD 5 2 0 1 0 0d 7 11 
PD013 M 73 27 tdPD 7 2 0 2 3 3 8 7 
PD014 M 61 26 tdPD 5 2 2 3 0 0 10 11 
MMSE = Mini Mental State Examination; D = Diagnosis; PD = Parkinson's disease; tdPD = Tremor dominant Parkinson's Disease; H&Y = Hoehn 
and Yahr score; OFF = off medication, after overnight withdrawal of anti-parkinsonian medication; ON = on medication, 1 hour after taking 
medication; Med = Medication;  MDS-UPDRS-III = the motor part (part III) of the Movement Disorder Society revision of the Unified Parkinson's 
Disease Rating Scale; Bradykinesia subscore = sum of right hand items on 'finger tapping', 'hand movements', and 'pronation-supination movement 
of the hand'; Tremor subscore = sum of right hand tremor-items;  Purdue pegboard Right hand score = number of pins inserted with the right hand 
in 30 seconds. a) For these patients the ‘Hand movements’ score of the right hand was missing. b) For this patients the ‘Finger tapping’ score of the 
right hand was missing. c) For these patients the 'Kinetic tremor' scores for the right hand were missing. d) For these patients the 'Postural tremor' 
score of the right hand was missing. ** For this patient too many items were missing. 
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showed tremor during the resting task at ON medication, while 
relative power clearly decreased. Tremor frequencies for 
PD013 during the circle and spiral tasks were available at ON 
medication, while relative power did not clearly decrease. Only 
PD011 and PD013 had a MDS-UPDRS-III-tremor score higher 
than 0 (see Table 3).  
 
 
Figure 2. Scatterplots and regression lines for the right hand score on the Purdue 
pegboard test against movement time on the circle tracing task (Upper plot; 
Spearman’s rho = -0.69) and against movement time on the spiral tracing task 
(Bottom plot; Spearman’s rho = -0.63). 
IV. DISCUSSION 
This study explored whether a set of graphical tasks could be 
used for monitoring PD by assessing its validity and response 
to dopaminergic medication.  Moderate correlations between 
performance on graphical tasks and the PPT suggest that this 
set of graphical tasks is valid to assess and monitor upper limb 
function in PD patients. The advantage of using these graphical 
tasks, instead of, for instance, the PPT is that no examiner is 
needed, which makes the graphical tasks suitable for home-
based monitoring. Additionally, this study showed that this set 
of graphical tasks can be used to detect subtle changes, which 
are barely visible by observing the patient, in performance after 
taking medication in PD patients. We investigated the validity 
and response to dopaminergic medication of different measures 
of MT on graphical tasks to assess bradykinesia. 
Moderate correlations with the PPT score suggest that MT 
measures for the tracing tasks are valid for assessing and 
monitoring upper limb function in PD patients. In contrast, MT 
measures for the writing task showed only weak correlations 
with the PPT and seem to be less valid. FittsSlope, referring to 
the extent to which a patient becomes slower with increasing 
difficulty of Fitts’ task, also correlated significantly with the 
PPT score, which means that FittsSlope can be used as a proper 
measure of bradykinesia. In agreement with previous studies 
regarding medication effects on performance of graphical tasks 
in PD [12], [14], [15], MT on the writing task improved after 
taking medication (see Table 2). In addition, FittsSlope and MT 
on the simple circle and spiral tracing tasks also improved after 
taking medication in PD patients. Simple circle and spiral 
tracing tasks might be easier to perform correctly than a writing 
task in home-based settings without an examiner present. We 
also studied the validity and response to dopaminergic 
medication of different measures of tremor (presence or 
absence of tremor, tremor frequency and relative power around 
the tremor frequency) during the resting task and circle and 
spiral tracing tasks. The present study showed that tremor 
power generally decreased after medication intake in PD 
patients, which was reported previously as well [29]. Since 
tremor often is a prominent and disabling symptom of PD that 
may be influenced by treatment, a useful monitoring tool should 
include a measure to assess tremor. Previous studies 
investigating medication effects on graphical tasks did not 
include a measure to assess tremor [11], [12], [14], [15]. 
Remarkably, MDS-UPDRS-III-tremor scores were 0 for almost 
all patients, although a tremor was detected during the graphical 
tasks. This suggests that graphical tasks might be more sensitive 
to detect a subtle tremor than the UPDRS. The difference in the 
presence of tremor between the UPDRS and the graphical tasks 
could be explained by the fact that tremor scoring during the 
UPDRS involves observing movements of the upper limb 
different from the movements which are involved in the 
graphical tasks. For example, a clinician observes whether 
tremor is present during a simple flexion movement of the 
upper limb, whereas the graphical tasks require more complex 
movements of the upper limb. In addition, a tremor with a low 
amplitude and high frequency could be difficult to observe 
























































TABLE II.  
TEST STATISTICS OF THE RESPONSE TO DOPAMINERGIC MEDICATION. MEDIAN 
AND INTERQUARTILE RANGE (IQR) VALUES ARE PROVIDED FOR BOTH ‘ON’ 
(ON) AND ‘OFF’ MEDICATION (OFF). 
 OFF ON Z-valuea p-value 
CircleMT (s) b 4.16 (5.56) 4.12 (3.39) -2.55 0.01* 
SpiralMT (s) 11.42 (10.12) 9.74 (10.93) -2.61 0.01** 
ZZMT (s) c 11.92 (3.81) 11.55 (8.04) -1.18 0.24 
E_MT (s) 0.39 (0.12) 0.36 (0.14) -2.17 0.03* 
L_MT (s) 0.52 (0.22) 0.48 (0.13) -2.67 0.01** 
E_width  (mm) 9.23 (2.83) 7.79 (4.46) -0.41 0.68 
E_height  (mm) 14.87 (7.79) 15.26 (11.06) -0.22 0.83 
L_width  (mm) 12.84 (7.58) 12.81 (11.05) -0.03 0.97 
L_height  (mm) 39.14 (18.86) 41.20 (26.12) -0.03 0.97 
FittsSlope d 0.14 (0.09) 0.12 (0.08) -2.22 0.03* 
FittsR2  d 0.89 (0.16) 0.93 (0.08) -1.87 0.09 
MT = Movement Time. a) Results of the related-samples Wilcoxon signed 
rank test. b) Data of PD007 were missing, due to a technical problem. c) Data 
of PD002 and PD006 were missing, due to a technical problem. d) Data of 
PD001, PD002 and PD003 were missing, due to a technical problem. * 
statistically significant at α = 0.05; ** statistically significant at α = 0.01 
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during a neurological assessment, while graphical tasks 
performed with a sensor pen could capture such tremors. 
  Besides bradykinesia and tremor, micrographia is a 
common symptom in PD patients [5], [22], [30], which refers 
to a reduction in writing size and could be assessed 
quantitatively [5]. For screening PD, assessing micrographia 
has been shown to be useful, because differences were found 
between mildly affected PD and HC participants [31]. Our data 
showed that writing size measures correlated weakly with the 
PPT, suggesting that writing size, as assessed in this study, is 
not a valid measure to assess and monitor upper limb function 
in PD.   
Additionally, writing size measures did not change after 
taking medication in PD patients, in agreement with previous 
studies that investigated writing size ON and OFF medication 
[11]–[13]. However, duration and size of writing are related [5], 
[8], so bradykinesia could compensate for micrographia. 
Therefore, micrographia assessments could be improved by 
writing a fixed number of letters or words in a particular time 
frame. 
 No significant correlations were found between 
performance on graphical tasks and the MDS-UPDRS-III-
bradykinesia score. This could be explained by the fact that the 
MDS-UPDRS-III-bradykinesia items entail different 
movements of the arm and hand than graphical tasks and 
therefore involve other upper limb functions. Hand function of 
most PD patients in this study was only mildly affected, 
according to the MDS-UPDRS-III-bradykinesia subscore. 
Subtle improvements of hand function after taking medication 
were therefore hard to detect according to the MDS-UPDRS-
III. In contrast, performance of almost all PD patients improved 
on graphical tasks after taking medication, which suggests that 
graphical tasks are more suitable to detect subtle changes in 
upper limb function than the MDS-UPDRS-III.  
 To use the current system as a home-based monitoring 
tool, the analysis methods should and could be converted to 
automatic methods, which generate simple outcome measures 
for the clinician. In addition, a home-based system should 
include a clear instruction manual for patients and error 
detection and feedback to ensure correct task execution and 
allow use of the system without an examiner present. Once the 
system is fully automated, a new study would be needed to re-
assess validity. To further investigate long-term disease 
progression and treatment effects, a longitudinal study should 
be performed in which PD patients will be followed for a longer 
time-period. 
 As a limitation, the medication effects in this study may 
have been influenced by a learning effect, because the 
measurements ON medication were performed approximately 
1.5 hours after the measurements OFF medication. However, 
since the tasks were easy to perform and not all patients 
improved at the second measurement, it is assumed that this 
learning effect is not substantial. Another limitation of this 
study is that the resting task involved holding the pen-tip at a 
certain location, which makes it a postural rather than a resting 
task. Therefore this task is not suited to assess resting tremor. 
Since resting tremor is typical for PD patients, another resting 
task should be included in future studies that actually measures 
resting tremor. Furthermore, it would be interesting to assess 
the responsiveness of the graphical tasks. This could be done by 
comparing the change in performance on the graphical tasks 
with the clinically accepted change between ON and OFF 
medication. The clinically accepted change for PD patients 
would be a change in the UPDRS score. Since the patients in 
our study were only mildly affected and showed low UPDRS 
scores, a clear change in UPDRS was often not seen between 
ON and OFF medication. Therefore we did not compare the 
changes in graphical tasks to the small and often absent changes 
in UPDRS score, but only compared performance on the 
graphical tasks ON and OFF medication and pooled 
measurements ON and OFF medication to allow assessment of 
the validity of the graphical tasks. 
In conclusion, the present study showed that our set of 
graphical tasks using a digital tablet and sensor-pen is valid to 
assess and monitor upper limb functioning in PD patients, 
especially with respect to the circle, spiral and modified Fitts’ 
task and their derived measures of MT and tremor. Our method 
is non-invasive, portable and can be used easily at home without 
an examiner, which offers great opportunities as an endpoint for 
future medication trials.  
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